Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 395, Issue 2-3, 1997, Pages 179-187

  Werner, S ^a   Kunz, S ^a   Beckurts, T ^b   Heidecke, C D ^b   Wolff, T ^a   Schwarz, L R ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Chirurgische Klinik und Poliklinik   (Germany)

Author keywords

Cyproterone acetate; DNA adducts; Human hepatocyte

Indexed keywords

CHLORMADINONE ACETATE; CYPROTERONE ACETATE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PROGESTERONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA BINDING; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANDROGEN ANTAGONISTS; CELLS, CULTURED; CHLORMADINONE ACETATE; CYPROTERONE ACETATE; DNA ADDUCTS; FEMALE; HUMANS; LIVER; MALE; MEDROXYPROGESTERONE 17-ACETATE; MEGESTROL ACETATE; MIDDLE AGED; PROGESTERONE; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICITY TESTS;

EID: 0031566025     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(97)00167-8     Document Type: Article

References (34)

1. Topinka J., Andrae U., Schwarz L.R., Wolff T. Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures. Carcinogenesis. 14:1993;423-427.
2. Topinka J., Binkova B., Schwarz L.R., Wolff T. Cyproterone acetate is an integral part of hepatic DNA adducts induced by this steroidal drug. Carcinogenesis. 17:1996;167-169.
3. Werner S., Topinka J., Wolff T., Schwarz L.R. Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver. Carcinogenesis. 16:1995;2369-2372.
4. Topinka J., Binkova B., Zhu H.K., Andrae U., Neumann I., Schwarz L.R., Werner S., Wolff T. DNA damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver. Carcinogenesis. 16:1995;1483-1487.
5. Neumann I., Thierau D., Andrae U., Greim H., Schwarz L.R. Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in g-glutamyltranspeptidase-positive cells. Carcinogenesis. 13:1992;373-378.
6. Martelli A., Mattioli F., Fazio S., Andrae U., Brambilla G. DNA repair synthesis and DNA fragmentation in primary cultures of human and rat hepatocytes exposed to cyproterone acetate. Carcinogenesis. 16:1995;1265-1269.
7. Kasper P., Tegethoff K., Mueller L. In vitro mutagenicity studies on cyproterone acetate using female rat hepatocytes for metabolic activation and as indicator cells. Carcinogenesis. 16:1995;2309-2314.
8. Kasper P., Müller L. Time-related induction of DNA repair synthesis in rat hepatocytes following in vivo treatment with cyproterone acetate. Carcinogenesis. 17:1996;2271-2274.
9. Feser W., Kerdar R.S., Blode H., Reimann R. Formation of DNA-adducts by selected sex steroids in rat liver. Human Exp. Toxicol. 15:1996;556-562.
10. Deml E., Schwarz L.R., Oesterle D. Initiation of enzyme-altered foci by the synthetic steroid cyproterone acetate in rat liver foci bioassay. Carcinogenesis. 14:1993;1229-1231.
11. Martelli A., Brambilla Campart G., Ghia M., Allavena A., Mereto E., Brambilla G. Induction of micronuclei and initiation of enzyme altered foci in the liver of female rats treated with cyproterone acetate, chlormadinone acetate or megestrol acetate. Carcinogenesis. 17:1996;551-554.
12. Martelli A., Mattioli F., Ghia M., Mereto E., Brambilla G. Comparative study of DNA repair induced by cyproterone acetate, chlormadinone acetate and megestrol acetate in primary cultures of human and rat hepatocytes. Carcinogenesis. 17:1996;1153-1156.
13. Strom S.C., Jirtle R.L., Jones R.S., Novicki D.L., Rosenberg M.R., Novotny A., Irons G., McLain J.R., Michalopoulos G. Isolation, culture and transplantation of human hepatocytes. J. Natl. Cancer Inst. 68:1982;771-778.
14. Reese J.A., Byard J.L. Isolation and culture of adult hepatocytes from liver biopsies. In Vitro. 17:1981;935-940.
15. G.W. Sandker, Isolated hepatocytes: a research tool for investigations on drug transport, drug metabolism and liver transplantaion, Thesis, Rijksuniversiteit Groningen, Netherlands, 1993, p. 69.
16. Ducore J.M. EDTA alkaline elution characteristics and measurement of DNA damage in unlabeled DNA using Hoechst 33254 fluorescence. Environ. Mol. Mutagen. 11:1988;449-460.
17. 32P -postlabeling analysis of aromatic carcinogen adducts Cancer Res. 45:1985;5656-5662.
18. Gupta R.C., Dighe N.R. Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofluorene, 4-acetylaminobiphenyl and 2-acetylaminophenanthrene. Carcinogenesis. 5:1984;343-349.
19. S. Werner, Untersuchungen zur Gentoxizität von Cyproteronacetat, einem in der Humantherapie verwendeten synthetischen Sexualsteroid, Thesis, Fakultät für Chemie, Biologie and Geowissenschaften, Technische Universität München, Germany, 1996.
20. Werner S., Kunz S., Wolff T., Schwarz L.R. The steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation. Cancer Res. 56:1996;4391-4397.
21. Kerdar R.S., Baumann A., Brudny-Klöppel M., Biere H., Blode H., Kuhnz W. Identification of 3a-hydroxy-cyproterone acetate as a metabolite of cyproterone acetate in the bile of female rats and the potential of this and other already known or putative metabolites to form DNA adducts in vitro. Carcinogenesis. 16:1995;1835-1841.
22. 32P -Postlabeling technique Pharmacol. Toxicol. 78:1996;214-223.
23. Watabe T., Ogura K., Satsukawa M., Okuda H., Hiratsuka A. Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalysing covalent binding of carcinogenic polycyclic arylmethanols to DNA. Chem.-Biol. Interact. 92:1994;87-105.
24. Homma H., Nakagome I., Kamakura M., Hirota M., Takahashi M., Matsui M. Studies on rat hepatic hydroxysteroid sulfotransferase-immunochemistry, development and pI variants. Chem.-Biol. Interact. 92:1994;15-24.
25. Aksoy I.A., Sochorova V., Weinshilboum R. Human liver dehydroepiandrosterone sulfotransferase: nature and extent of individual variation. Clin. Pharmacol. Ther. 54:1993;498-506.
26. Handy R.W., Palmer K.H., Wall M.E., Piantadosi C. The metabolism of antifertility steroids; the in vitro metabolism of chlormadinone acetate. Drug. Metab. Disp. 2:1974;214-220.
27. Cooke B.A., Vallance D.K. Metabolism of megestrol acetate and related progesterone analogues by liver preparations in vitro. Biochem. J. 97:1965;672-677.
28. Kuhnz W., Staks T., Jütting G. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles. Contraception. 48:1993;557-575.
29. Lang R., Redmann U. Non-mutagenicity of some sex hormones in the Ames Salmonella/microsome mutagenicity test. Mutation Res. 67:1979;361-365.
30. Lang R., Reimann R. Studies for a genotoxic potential of some endogenous and exogenous sex steroids. I. Communication: examination for the induction of gene mutations using the Ames Salmonella/Microsome Test and the HGPRT Test in V79 cells. Environ. Mol. Mutagen. 21:1993;272-304.
31. Glatt H., Henschler R., Phillips D.H., Blake J.W., Steinberg P., Seidel A., Oesch F. Sulfotransferase-mediated chlorination of 1-hydroxymethylpyrene to a mutagen capable of penetrating indicator cells. Environ. Health Perspect. 88:1990;43-48.
32. Czich A., Bartsch I., Dogra S., Hornhardt S., Glatt H.R. Stable heterologous expression of hydroxysteroid sulphotransferase in Chinese hamster V79 cells and their use for toxicological investigations. Chem.-Biol. Interact. 92:1994;119-128.
33. G. VanKaick, H. Wesch, Follow-up study (results), in: G. Van Kaick, H. Muth, A. Kaul (Eds.), The German Thorotrast Study, Commission of the European Communities, Office for Official Publications of the European Communities, Luxembourg, 1984, pp. 190-211.
34. D.M. Parkin, C.S. Muir, Whelan, Y.T. Gao, J. Ferlay, J. Powell (Eds.), Cancer Incidence in Five Continents, vol. VI, IARC Scientific Publications No. 120, International Agency for Research on Cancer, Lyon, 1992, p. 433.